This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.
Company Profile:
Leap Therapeutics, Inc.
Market Cap (USD):
$82.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
VistaGen Therapeutics, Inc.
Market Cap (USD):
$82.1 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ikena Oncology, Inc.
Market Cap (USD):
$82.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Alligator Bioscience AB
Market Cap (USD):
$82.0 M
(July 1, 2024)
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Biotechnology
Company Profile:
X4 Pharmaceuticals, Inc.
Market Cap (USD):
$81.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
GlycoNex InCorp
Market Cap (USD):
$81.1 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Decibel Therapeutics, Inc.
Market Cap (USD):
$80.3 M
(July 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Biofrontera AG
Market Cap (USD):
$80.2 M
(March 1, 2022)
Country:
Germany
Sector:
German Healthcare
Industry:
German Biotechnology
Company Profile:
AnGes, Inc.
Market Cap (USD):
$78.1 M
Country:
Japan
Sector:
Japanese Healthcare
Industry:
Japanese Biotechnology
Company Profile:
ESSA Pharma Inc.
Market Cap (USD):
$78.1 M
Country:
Canada
Sector:
Canadian Healthcare
Industry:
Canadian Biotechnology
Company Profile:
Chunghwa Chemical Synthesis & Biotech Co. Ltd
Market Cap (USD):
$78.1 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Armata Pharmaceuticals Inc.
Market Cap (USD):
$77.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Tiziana Life Sciences plc
Market Cap (USD):
$77.1 M
(Oct. 1, 2021)
Country:
United Kingdom
Sector:
UK Healthcare
Industry:
UK Biotechnology
Company Profile:
Hofseth BioCare ASA
Market Cap (USD):
$76.7 M
(July 1, 2024)
Country:
Norway
Sector:
Norway Healthcare
Industry:
Norway Biotechnology
Company Profile:
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA
Market Cap (USD):
$76.7 M
Country:
Poland
Sector:
Polish Healthcare
Industry:
Polish Biotechnology
Company Profile:
Galectin Therapeutics, Inc.
Market Cap (USD):
$76.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
bluebird bio, Inc.
Market Cap (USD):
$76.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
BRAIN Biotechnology Research & Information Network AG
Market Cap (USD):
$76.2 M
Country:
Germany
Sector:
German Healthcare
Industry:
German Biotechnology
Company Profile:
Vicapsys Life Sciences, Inc.
Market Cap (USD):
$76.1 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Adicet Bio, Inc.
Market Cap (USD):
$76.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Biostage, Inc.
Market Cap (USD):
$75.9 M
(Jan. 1, 2023)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Applied Therapeutics, Inc.
Market Cap (USD):
$74.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
JW
Market Cap (USD):
$73.7 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Cantargia AB
Market Cap (USD):
$73.5 M
(July 1, 2024)
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Biotechnology
Company Profile:
Genovate Biotechnology Co. Ltd
Market Cap (USD):
$72.2 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
PMV Pharmaceuticals, Inc.
Market Cap (USD):
$71.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Paradigm Biopharmaceuticals Limited
Market Cap (USD):
$71.3 M
(July 1, 2024)
Country:
Australia
Sector:
Australian Healthcare
Industry:
Australian Biotechnology
Company Profile:
DBV Technologies SA
Market Cap (USD):
$70.7 M
Country:
France
Sector:
French Healthcare
Industry:
French Biotechnology
Company Profile:
Clearside Biomedical, Inc.
Market Cap (USD):
$70.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
CytomX Therapeutics, Inc.
Market Cap (USD):
$69.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology